Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2007
10/17/2007EP1844771A2 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
10/17/2007EP1844052A1 Thieno[2,3-d]pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
10/17/2007EP1844050A1 Pyrrolopyrimidines useful as inhibitors of protein kinase
10/17/2007EP1843760A1 Classes of compounds that interact with integrins
10/17/2007EP1541589B1 Fused protein with the function of both thrombolysis and anticoagulation and the use of it
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
10/17/2007EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007CN101056856A Method for preparing torsemide crystal with pure state
10/17/2007CN101056662A Adhesion preventive material and method of preventing adhesion
10/17/2007CN101056633A Pi3 kinase gamma inhibitors for the treatment of anaemia
10/17/2007CN101054346A Preparation method and use for a set of novel compound and composition thereof
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053661A Tetramethylpyrazine derivatives modified silk fibroin protein fiber anti-coagulant material and its preparation method
10/17/2007CN101053554A Ginkgolide B powder injection and its preparation method
10/17/2007CN101053435A Blood-nourishing wind-expelling beverage
10/17/2007CN101053428A Blood-enriching and blood-promoting circulation matrimony vine beverage
10/17/2007CN101053423A Longan and lotus seed soup
10/17/2007CN101053412A Pork liver blood-enriching soup
10/17/2007CN101053400A Oral liquid for male fat reduction
10/17/2007CN101053390A Lotus roots blood-nourishing soup
10/17/2007CN101053382A Sichun fritillary bulb wax gourd moon cake
10/17/2007CN101053375A Eggs with non-pollution and building up body functions
10/17/2007CN101053354A Producing technology for natural pine needle tea
10/17/2007CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007CN100342856C Composition of danazol semisolid skeleton preparation
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282480 Aqueous sustained-release formulations of proteins
10/16/2007US7282368 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
10/16/2007US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery
10/16/2007US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
10/16/2007US7282201 Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin
10/16/2007US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders
10/16/2007CA2272584C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
10/11/2007WO2007114791A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007WO2007114526A1 Process for producing high-purity prasugrel and acid addition salt thereof
10/11/2007WO2007114262A1 Casein nanoparticle
10/11/2007WO2007113170A1 Use of strobilurins for treating malfunctions of the iron metabolism
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070237819 Use of sustained release oral solid dosage form; side effect reduction of liver disoders
10/11/2007CA2648598A1 Lactate and calcium containing pharmaceutical composition and uses thereof
10/11/2007CA2648503A1 Method for producing high-purity prasugrel or an acid addition salt thereof
10/11/2007CA2644642A1 A process for concentration of a polypeptide
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
10/10/2007EP1841504A2 Substituted biaryl compounds as factor xia inhibitors
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1511859B1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
10/10/2007EP1480659B1 Use of zeolithes for reducing the proportion of lactates in human and animal organisms
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/10/2007CN101050193A Nitric ester derivatives, its medicinal composition and their medicinal use
10/10/2007CN101050011A Membrane filtered drinkable mineral raw water containing selenium and germanium
10/10/2007CN101049462A í«Naoxinaní» tablet in use for cardiovascular disease, cerebrovascular disease and preparation method
10/10/2007CN101049441A Capsule for treating aplastic anemia, and producing method
10/10/2007CN101049382A External spraying agent for treating circulatory disturbance of blood vessels of heart and brain
10/10/2007CN101049356A Pharmaceutical composition of containing puerarin and leaves of hawthorn
10/10/2007CN101049344A Pharmaceutical composition of Qishen in use for treating leucopenia, and preparation method
10/10/2007CN101049339A Method for preparing injection of astragalus
10/10/2007CN101049334A Pale rose color drop pills
10/10/2007CN101049330A Method for preparing extractive of Chinese traditional medicine rich in coniferyl alcohol ferulic acid, and application in preparing medication, health products, or cosmetic
10/10/2007CN101049329A Application of angelica oil in raising level of estradiol from internal source for treating estradiol related disease
10/10/2007CN101049296A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
10/10/2007CN100341575C Water soluble dry compositions
10/10/2007CN100341530C Method for preparing Chinese angelica blood supplementing micro pill
10/10/2007CN100341518C Use of sulfated glycosaminoglycans for establishing effective labor in women
10/10/2007CN100341509C Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/10/2007CN100341506C Medical compositions containing aspirin
10/10/2007CN100341493C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/10/2007CN100341428C Nutritional composition preventing bacterial overgrowth
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279183 Particularly magnesium sulfate, magnesium oxide, magnesium phosphate, or magnesium chloride
10/09/2007US7279161 Treating patients afflicted with hemophilia A by administering an antibody that binds factor IX/factor IXa and increases the procoagulant activity of FIXa
10/09/2007US7279156 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells.
10/09/2007CA2252084C Cytoprotective compounds
10/09/2007CA2161857C Oxazolidinone derivatives as adhesion receptor antagonists
10/04/2007WO2007111212A1 Triazolone derivative
10/04/2007WO2007111203A1 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
10/04/2007WO2007088343A8 Granular material comprising water- insoluble inorganic phosphate binders
10/04/2007WO2007070899A3 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms
10/04/2007WO2006094810A3 Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
10/04/2007US20070232796 Medical Solution, a Method for Producing Said Medical Solution and Use Thereof
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 671